School of Medicine
Showing 2,901-2,950 of 13,056 Results
-
Alexander Dunn
Professor of Chemical Engineering
Current Research and Scholarly InterestsMy lab is deeply interested in uncovering the physical principles that underlie the construction of complex, multicellular animal life.
-
James Dunn
Professor of Surgery (Pediatric Surgery)
Current Research and Scholarly InterestsIntestinal lengthening for short bowel syndrome
Intestinal stem cell therapy for intestinal failure
Skin derived precursor cell therapy for enteric neuromuscular dysfunction
Intestinal tissue engineering -
Jeffrey Dunn, MD
Clinical Professor, Adult Neurology
Current Research and Scholarly InterestsTranslational research in the human application of emerging immunotherapies for neurological disease, focusing on Multiple Sclerosis, CIS, transverse myelitis and Neuromyelitis Optica (NMO). Collaborative research with Stanford and extramural scientific faculty to identify biomarkers of disease activity and treatment response in humans. Clinical trials to assess efficacy of emerging treatments for MS, CIS and NMO.
-
Tamara Dunn
Clinical Associate Professor, Medicine - Hematology
BioDr. Tamara Dunn is a clinical associate professor in the Division of Hematology at the Stanford University School of Medicine. She is a clinician with a special interest in medical education, diversity, equity, and inclusion. Specifically, she is committed to improving workforce diversity and creating inclusive workplaces. She is currently the Program Director for the Stanford Hematology/Oncology Fellowship and one of the Associate Chairs of Diversity and Inclusion for the Department of Medicine at Stanford. She is a member of the inaugural American Society of Hematology (ASH) Ambassador Cohort and serves on the ASH Women in Hematology committee, which she co-chairs. She is on the steering committee and is a mentor for Stanford’s Leadership Education in Advancing Diversity (LEAD) program. She takes pride in treating underserved veterans at the Palo Alto Veterans Hospital, where she sees both classical and malignant hematology. Outside of medicine she enjoys singing, dancing, sports (Go Chiefs! Go Warriors!), board games, movies, and spending time with friends and family including her 3 young children, spouse, and energetic vizsla Casey.
-
Mary Laurence Dunne
Adjunct Professor, Medicine - Primary Care and Population Health
BioDr. Mimi Dunne is a physician leader in palliative and emergency medicine with a longstanding commitment to innovation in end-of-life care and medical education. A 2019-2020 Stanford Distinguished Careers Institute Fellow, Dr. Dunne has co-taught MED 296: Being Mortal at Stanford University School of Medicine.
A graduate of Saint Louis University School of Medicine, she completed postgraduate training at the University of Chicago, certification in Mindfulness-Based Stress Reduction at the University of Massachusetts, and is board-certified in both Emergency Medicine and Hospice and Palliative Medicine. As Medical Director of Hudson Valley Hospice, she founded the region’s first palliative care program in 2001.
Her scholarly work spans emergency medicine, palliative medicine, and global health, and she has authored studies, articles, and book chapters in these fields. She currently serves as an advisor to the African Center for Research in End of Life Care in Rwanda and to Bulamu Health Care in Uganda. -
Sebastian Duno-Miranda
Postdoctoral Scholar, Biochemistry
BioI started my training as a biologist at the Universidad Central de Venezuela (UCV) and the Instituto Venezolano de Investigaciones Cientificas (IVIC). My Licentiate thesis degree advisor was Dr. Raúl Padrón, whom with I studied the structure and function of tarantula muscle, a key non-conventional animal model to understand muscle function in humans. Next, I would move to pursue doctoral studies at the University of Vermont, under Dr. David M. Warshaw supervision, studying the molecular mechanics of human cardiac myosin, the motor responsible for powering up the contractions of the human heart, the effect of multiple cardiomyopathy mutations, and the application of machine learning to enhance myosin single-molecule data analysis. Now, I've joined the lab of Dr. James Spudich at Stanford University, to continue pushing the frontiers of knowledge regarding the molecular physiology of human myosins in the context of heart disease. For more details please see https://duno-miranda.org
-
Ashley DuNova
Graduate, Biodesign Program
BioCollaborating with Dr. Michael Snyder and the Snyder Lab.
ORCID: https://orcid.org/0000-0002-1478-7065 -
Jonathan Anh Quan Duong
Clinical Associate Professor, Medicine
BioDr. Jonathan Duong is an Associate Professor in the Division of Hospital Medicine at Stanford University School of Medicine. He practices clinically as a hospitalist on inpatient medicine services at Stanford Health Care. He completed his medical school and internal medicine residency at University of Texas Southwestern Medical Center and the Academic Hospital Medicine Fellowship at University of California, San Francisco.
Dr. Duong is a clinician-educator whose academic interests center on faculty development, medical education, and clinical operations. Prior to joining Stanford, he directed a faculty development program in hospital medicine and served as an associate program director for an internal medicine residency. At Stanford, he contributes to faculty recruitment and division mentorship. He formed the Hospital Medicine Direct Care (attending only) Service at Stanford, including a hospital medicine elective for residents and medical students. -
Nikki Duong, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research interests focus on quality improvement and patient reported outcomes in people with cirrhosis. I also have interests in expanding our breadth of knowledge in caring for patients with gastrointestinal and liver disorders who identify as a sexual and gender minority.
-
Tina Duong MPT, PhD
Sr Res Scientist-Basic Life, Adult Neurology
BioAs the Director of Clinical Outcomes and Research Development, and the Co-Founder and Co-Director of the Neuro-IGNITE Center at the Stanford University School of Medicine, I focus on translational rehabilitation science, psychometric measurement theory, clinical outcomes development, trial design, and digital health technology for individuals with neuromuscular disorders.
My research is guided by a simple premise: measurement determines access. Individuals who are harder to measure, and constructs that are meaningful to patients but difficult to quantify, are frequently overlooked in clinical trials, limiting both trial participation and treatment access. Complementing established functional scales, our team works to bridge this gap by defining the concept of interest and context of use with patients, clinicians, and regulators, then developing and validating fit-for-purpose clinical outcome assessments and digital endpoints across neuromuscular disorders, including spinal muscular atrophy, Duchenne muscular dystrophy, myotonic dystrophy, and facioscapulohumeral muscular dystrophy. This alignment supports a clearer regulatory path so that patients who have been difficult to measure can qualify for trials, demonstrate meaningful benefit, and gain access to therapies.
Bridging clinical expertise and computational engineering, I collaborate with bioengineers to integrate digital health tools, including markerless motion capture (OpenCap) and multimodal sensors (wearables, video and imaging biomarkers, cardiopulmonary exercise testing) into clinical research. Together, we aim to better understand disease mechanisms and functional impact across the drug development pipeline. This work has contributed high-resolution, video-based kinematic datasets and minimal clinically important difference (MCID) thresholds that inform regulatory benchmarks for clinical trials and therapeutic evaluations.
Key Academic & Research Focus Areas:
•Outcome Measure Development & Psychometrics: Developing and validating functional instruments and digital biomarkers designed to meet regulatory standards in rare diseases.
•Digital Biomechanics & Kinematic Modeling: Applying markerless motion capture and wearable inertial sensors to quantify disease progression and subtle changes in movement.
•Translational Clinical Trial Design: Advising on endpoint selection and contributing to international natural history studies to improve trial readiness, reduce participant burden, and strengthen statistical sensitivity.
•Scientific Leadership & Mentorship: Leading multi-center academic consortia, publishing peer-reviewed research, and mentoring the next generation of clinical researchers. -
George Duran
Cancer Biologist and Laboratory Manager, Medicine - Med/Oncology
Current Role at StanfordCancer biologist specializing in the development of novel chemotherapeutic agents and in mechanisms of drug resistance. Current research ranges from molecular studies to further understand the heterogeneity of T-cell lymphomas, to translational studies of molecular determinants of therapeutic response, and clinical trials that use the body’s immune system to fight cancer cells.
Original research contributions have resulted in the authorship of over eighty publications. -
Benjamin J. Durant, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Benjamin Durant is a board-certified family medicine doctor at Stanford Health Care and a clinical assistant professor in the Department of Medicine, Division of Primary Care and Population Health at Stanford University School of Medicine.
Dr. Durant provides complete primary care for people of all ages, with a strong focus on health equity and supporting underserved communities. His clinical interests include outpatient care, prenatal and reproductive health, and treating substance use disorders. He has extensive experience in street medicine and mobile outreach to care for people experiencing homelessness. Dr. Durant takes a trauma-informed, relationship-based approach, building trust and meeting patients where they are.
His academic and service work has focused on improving access to care, training health care workers in under-resourced areas, and helping patients who face challenges like poverty, housing insecurity, or limited access to services. Dr. Durant’s approach to medicine is built on dignity, trust, and long-term relationships. He is committed to understanding and addressing the social factors that affect health. He has also volunteered internationally in Kenya and Haiti. -
Timothy Durazzo
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe mission of the Durazzo BRASS lab is to better understand how the interplay between biomedical, psychological and social factors influence treatment outcome in Veterans and civilians seeking treatment for alcohol and substance use disorders. To accomplish this mission, our multidisciplinary team integrates information from advanced neuroimaging, neurocognitive assessment, psychodiagnostic and genotyping methods to identify the biopsychosocial factors associated with relapse and sustained sobriety. Data from Veteran's Administration and Stanford funded Clinical trials are currently being analyzed by the BRASS lab to evaluate the efficacy of repetitive transcranial magnetic stimulation techniques as novel complementary treatments to reduce the high rate of return to hazardous drinking experienced by individuals with alcohol and substance abuse disorders. The ultimate goal of our multidisciplinary research program is to promote the development of more effective biomedical and behavioral treatments for alcohol and substance use disorders through consideration of the brain biology, psychology and social circumstances of each individual.
-
Ram Duriseti
Clinical Associate Professor, Emergency Medicine
BioRam's Doctoral background and academic interests are in the computational modeling of complex decisions, algorithm design and implementation, and data driven decision making. Outside of clinical work, his main competencies in this regard are software development, algorithm design and implementation, cost-effectiveness analysis, and decision analysis through computational models. He has also collaborated with industry to create and deploy operation specific software involving statistical computing and reasoning under inference. He has been practicing clinical Emergency Medicine in both community and academic settings for over 20 years.
https://www.shiftgen.com/about
https://www.linkedin.com/in/ram-duriseti-991614/ -
Gozde Durmus
Assistant Professor (Research) of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsDr. Durmus' research focuses on applying micro/nano-technologies to investigate cellular heterogeneity for single-cell analysis and personalized medicine. At Stanford, she is developing platform technologies for sorting and monitoring cells at the single-cell resolution. This magnetic levitation-based technology is used for wide range of applications in medicine, such as, label-free detection of circulating tumor cells (CTCs) from blood; high-throughput drug screening; and rapid detection and monitoring of antibiotic resistance in real-time. During her PhD, she has engineered nanoparticles and nanostructured surfaces to decrease antibiotic-resistant infections.
-
Alex Maurice Dussaq
Clinical Assistant Professor, Pathology
BioAlex Maurice Dussaq, M.D., Ph.D., is an assistant professor of breast pathology and an associate director of pathology informatics. Dr. Dussaq holds a B.S. in Mathematics and Biochemistry from University of Nevada, Reno and an M.D./Ph.D. from University at Alabama, Birmingham. His Ph.D. focused on novel platform informatics and statistical analysis. He completed a Pathology residency and fellowships at Stanford in breast pathology and clinical informatics. Dr. Dussaq's research interests include the implementation and creation of workflow tools for surgical pathology and lab. He is particularly interested in whole slide image management systems and the future applications of artificial intelligence and large language models in pathology and medicine..
-
Suparna Dutt
Sr Res Scientist-Basic Life, Radiation Oncology - Radiation Therapy
Current Role at StanfordSr Research Scientist
-
David Eagleman
Adjunct Professor, Psych/Public Mental Health & Population Sciences
BioDavid Eagleman is a neuroscientist, bestselling author, and Guggenheim Fellow. Dr. Eagleman’s areas of research include sensory substitution, time perception, vision, and synesthesia. He also studies the intersection of neuroscience with the legal system, and in that capacity he directs the non-profit Center for Science and Law. Eagleman is the writer and presenter of The Brain, an Emmy-nominated television series on PBS and BBC. He is the author of 8 books, including Livewired, The Runaway Species, The Brain, Incognito, and Wednesday is Indigo Blue. He is also the author of a widely adopted textbook on cognitive neuroscience, Brain and Behavior. His internationally bestselling book of literary fiction, SUM, has been translated into 32 languages, turned into two operas, and named a Best Book of the Year by Barnes and Noble. Dr. Eagleman has been a TED speaker, a guest on the Colbert Report, and profiled in the New Yorker magazine. He has launched several neuroscience companies from his research, including Neosensory and BrainCheck.
